Centrosomal and mitotic abnormalities in cell lines derived from papillary thyroid cancer harboring specific gene alterations

Irena Maric, Silvia Viaggi, Paola Caria, Daniela V. Frau, Paolo Degan, Roberta Vanni

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Differentiated thyroid carcinoma offers a good model to investigate the possible correlation between specific gene mutations and chromosome instability. Papillary thyroid neoplasms are characterized by different mutually exclusive genetic alterations, some of which are associated with aneuploidy and aggressive phenotype. Results: We investigated the centrosome status and mitotic abnormalities in three thyroid carcinoma-derived cell lines, each maintaining the specific, biologically relevant gene alteration harbored by the parental tumors: RET/PTC1 rearrangement in TPC1; heterozygous and homozygous BRAF V600E mutation in K1 and in B-CPAP, respectively. B-CPAP cells showed a statistically significant (P <0.01) higher frequency of abnormal mitotic figures compared to TPC1 and K1 cells. Conclusions: Our data indicate that RET/PTC1 oncogenic activity is not related to mitotic chromosome impairment and missegregation whereas, based on the consistent difference in types/frequencies of centrosome and spindle abnormalities observed between K1 and B-CPAP cells, the hetero/homozygous allelic status of BRAF V600E mutation seems to be not irrelevant in respect to chromosomal instability development.

Original languageEnglish
Article number26
JournalMolecular Cytogenetics
Volume4
Issue number1
DOIs
Publication statusPublished - 2011

Fingerprint

Chromosomes
Thyroid Neoplasms
Centrosome
Chromosomal Instability
Genes
Cells
Cell Line
Mutation
Tumors
Aneuploidy
Phenotype
Papillary Thyroid cancer
Neoplasms

Keywords

  • BRAF
  • centrosome
  • mitotic spindle
  • RET/PTC
  • thyroid carcinoma

ASJC Scopus subject areas

  • Genetics
  • Molecular Biology
  • Genetics(clinical)
  • Biochemistry
  • Molecular Medicine
  • Biochemistry, medical

Cite this

Centrosomal and mitotic abnormalities in cell lines derived from papillary thyroid cancer harboring specific gene alterations. / Maric, Irena; Viaggi, Silvia; Caria, Paola; Frau, Daniela V.; Degan, Paolo; Vanni, Roberta.

In: Molecular Cytogenetics, Vol. 4, No. 1, 26, 2011.

Research output: Contribution to journalArticle

Maric, Irena ; Viaggi, Silvia ; Caria, Paola ; Frau, Daniela V. ; Degan, Paolo ; Vanni, Roberta. / Centrosomal and mitotic abnormalities in cell lines derived from papillary thyroid cancer harboring specific gene alterations. In: Molecular Cytogenetics. 2011 ; Vol. 4, No. 1.
@article{dcbd932aec3d41b898f8a8184e08fd29,
title = "Centrosomal and mitotic abnormalities in cell lines derived from papillary thyroid cancer harboring specific gene alterations",
abstract = "Background: Differentiated thyroid carcinoma offers a good model to investigate the possible correlation between specific gene mutations and chromosome instability. Papillary thyroid neoplasms are characterized by different mutually exclusive genetic alterations, some of which are associated with aneuploidy and aggressive phenotype. Results: We investigated the centrosome status and mitotic abnormalities in three thyroid carcinoma-derived cell lines, each maintaining the specific, biologically relevant gene alteration harbored by the parental tumors: RET/PTC1 rearrangement in TPC1; heterozygous and homozygous BRAF V600E mutation in K1 and in B-CPAP, respectively. B-CPAP cells showed a statistically significant (P <0.01) higher frequency of abnormal mitotic figures compared to TPC1 and K1 cells. Conclusions: Our data indicate that RET/PTC1 oncogenic activity is not related to mitotic chromosome impairment and missegregation whereas, based on the consistent difference in types/frequencies of centrosome and spindle abnormalities observed between K1 and B-CPAP cells, the hetero/homozygous allelic status of BRAF V600E mutation seems to be not irrelevant in respect to chromosomal instability development.",
keywords = "BRAF, centrosome, mitotic spindle, RET/PTC, thyroid carcinoma",
author = "Irena Maric and Silvia Viaggi and Paola Caria and Frau, {Daniela V.} and Paolo Degan and Roberta Vanni",
year = "2011",
doi = "10.1186/1755-8166-4-26",
language = "English",
volume = "4",
journal = "Molecular Cytogenetics",
issn = "1755-8166",
publisher = "BioMed Central Ltd.",
number = "1",

}

TY - JOUR

T1 - Centrosomal and mitotic abnormalities in cell lines derived from papillary thyroid cancer harboring specific gene alterations

AU - Maric, Irena

AU - Viaggi, Silvia

AU - Caria, Paola

AU - Frau, Daniela V.

AU - Degan, Paolo

AU - Vanni, Roberta

PY - 2011

Y1 - 2011

N2 - Background: Differentiated thyroid carcinoma offers a good model to investigate the possible correlation between specific gene mutations and chromosome instability. Papillary thyroid neoplasms are characterized by different mutually exclusive genetic alterations, some of which are associated with aneuploidy and aggressive phenotype. Results: We investigated the centrosome status and mitotic abnormalities in three thyroid carcinoma-derived cell lines, each maintaining the specific, biologically relevant gene alteration harbored by the parental tumors: RET/PTC1 rearrangement in TPC1; heterozygous and homozygous BRAF V600E mutation in K1 and in B-CPAP, respectively. B-CPAP cells showed a statistically significant (P <0.01) higher frequency of abnormal mitotic figures compared to TPC1 and K1 cells. Conclusions: Our data indicate that RET/PTC1 oncogenic activity is not related to mitotic chromosome impairment and missegregation whereas, based on the consistent difference in types/frequencies of centrosome and spindle abnormalities observed between K1 and B-CPAP cells, the hetero/homozygous allelic status of BRAF V600E mutation seems to be not irrelevant in respect to chromosomal instability development.

AB - Background: Differentiated thyroid carcinoma offers a good model to investigate the possible correlation between specific gene mutations and chromosome instability. Papillary thyroid neoplasms are characterized by different mutually exclusive genetic alterations, some of which are associated with aneuploidy and aggressive phenotype. Results: We investigated the centrosome status and mitotic abnormalities in three thyroid carcinoma-derived cell lines, each maintaining the specific, biologically relevant gene alteration harbored by the parental tumors: RET/PTC1 rearrangement in TPC1; heterozygous and homozygous BRAF V600E mutation in K1 and in B-CPAP, respectively. B-CPAP cells showed a statistically significant (P <0.01) higher frequency of abnormal mitotic figures compared to TPC1 and K1 cells. Conclusions: Our data indicate that RET/PTC1 oncogenic activity is not related to mitotic chromosome impairment and missegregation whereas, based on the consistent difference in types/frequencies of centrosome and spindle abnormalities observed between K1 and B-CPAP cells, the hetero/homozygous allelic status of BRAF V600E mutation seems to be not irrelevant in respect to chromosomal instability development.

KW - BRAF

KW - centrosome

KW - mitotic spindle

KW - RET/PTC

KW - thyroid carcinoma

UR - http://www.scopus.com/inward/record.url?scp=81055126963&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81055126963&partnerID=8YFLogxK

U2 - 10.1186/1755-8166-4-26

DO - 10.1186/1755-8166-4-26

M3 - Article

C2 - 22087789

AN - SCOPUS:81055126963

VL - 4

JO - Molecular Cytogenetics

JF - Molecular Cytogenetics

SN - 1755-8166

IS - 1

M1 - 26

ER -